Sanofi Aktie

45,80 EUR -5,20 EUR -10,20 %

24.04.2025

FSE

53,51 USD +0,43 USD +0,81 %

24.04.2025

BTT

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

JETZT LOSLEGEN

Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handeln Smartphone

KGV20,07Div. Rendite3,34%

WKN662283

ISINUS80105N1054

SymbolSNY

Sanofi Aktien News

Sortieren:Datum Meistgelesen

26.06.24EN, Sanofi-AventisPress Release: Dupixent positive phase 3 data in children one to 11 years of age with eosinophilic esophagitis published in NEJM

26.06.24BenzingaSanofi Looks To Sell $20B Icy Hot Division: Likely Bidders Include Advent, PAI Partners, Blackstone, CVC

25.06.24EN, Sanofi-AventisMedia Update: Riliprubart one-year follow-up from phase 2 study underpin the potential as a first-in-class treatment in chronic inflammatory demyelinating polyneuropathy

25.06.24GlobeNewswirePress Release: Availability of the Q2 2024 Aide-mémoire

25.06.24EN, Sanofi-AventisPress Release: Availability of the Q2 2024 Aide-mémoire

21.06.24GlobeNewswirePress Release: Audrey Duval Derveloy appointed Global Head of Corporate Affairs, member of Sanofi’s Executive Committee

21.06.24EN, Sanofi-AventisPress Release: Audrey Duval Derveloy appointed Global Head of Corporate Affairs, member of Sanofi’s Executive Committee

21.06.24GlobeNewswirePress Release: ISTH: Sanofi advances leadership in hemophilia with new data for ALTUVIIIO and fitusiran

21.06.24EN, Sanofi-AventisPress Release: ISTH: Sanofi advances leadership in hemophilia with new data for ALTUVIIIO and fitusiran

20.06.24GlobeNewswirePress Release: Sanofi and Biovac spearhead polio vaccine manufacturing capabilities in Africa

20.06.24EN, Sanofi-AventisPress Release: Sanofi and Biovac spearhead polio vaccine manufacturing capabilities in Africa

12.06.24GlobeNewswireSanofi: Information concerning the total number of voting rights and shares – May 2024

06.06.24PR NewswireI-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical Officer

04.06.24BenzingaSanofi Highlights Data From Blood Cancer Drug Sarclisa In New Diagnosed Multiple Myeloma Patients

03.06.24GlobeNewswirePress Release: ASCO: Sarclisa is first anti-CD38 to significantly improve progression-free survival in combination with VRd for newly diagnosed transplant-ineligible multiple myeloma in phase 3

03.06.24EN, Sanofi-AventisPress Release: ASCO: Sarclisa is first anti-CD38 to significantly improve progression-free survival in combination with VRd for newly diagnosed transplant-ineligible multiple myeloma in phase 3

02.06.24Financial TimesSanofi pushes ahead with €20bn consumer healthcare spin-off

01.06.24EN, Sanofi-AventisMedia Update: Sanofi update on Zantac litigation

31.05.24ZacksFDA Delays Decision on Sanofi (SNY)-Regeneron Dupixent in COPD

31.05.24GlobeNewswirePress Release: Sanofi launches 2024 global Employee Stock Purchase Plan

31.05.24EN, Sanofi-AventisPress Release: Sanofi launches 2024 global Employee Stock Purchase Plan

31.05.24GlobeNewswirePress Release: Dupixent recommended for EU approval by the CHMP to treat patients with COPD

31.05.24EN, Sanofi-AventisPress Release: Dupixent recommended for EU approval by the CHMP to treat patients with COPD

31.05.24GlobeNewswirePress Release: Update on FDA priority review of Dupixent for the treatment of COPD patients with type 2 inflammation

31.05.24EN, Sanofi-AventisPress Release: Update on FDA priority review of Dupixent for the treatment of COPD patients with type 2 inflammation

30.05.24GlobeNewswirePress Release: Sanofi completes acquisition of Inhibrx, Inc.

30.05.24EN, Sanofi-AventisPress Release: Sanofi completes acquisition of Inhibrx, Inc.

27.05.24GlobeNewswirePress Release: Sarclisa accepted for FDA priority review for the treatment of transplant-ineligible newly diagnosed multiple myeloma

27.05.24EN, Sanofi-AventisPress Release: Sarclisa accepted for FDA priority review for the treatment of transplant-ineligible newly diagnosed multiple myeloma

22.05.24BenzingaHawaii Court Rules Against Bristol Myers, Sanofi In Blood Clot Drug Case, Increases Liability To $916M

22.05.24EN, Sanofi-AventisMedia Update: New results from rilzabrutinib phase 2 study show potential to be first advanced oral treatment for moderate-to-severe asthma

21.05.24ZacksSanofi (SNY) Signs Deal for AI-Powered Drug Development

21.05.24BenzingaChatGPT Parent Open AI Partners With Sanofi, Formation Bio To Boost AI-Driven Drug Development

21.05.24GlobeNewswirePress Release: Sanofi, Formation Bio and OpenAI announce first-in-class AI collaboration

21.05.24EN, Sanofi-AventisPress Release: Sanofi, Formation Bio and OpenAI announce first-in-class AI collaboration

20.05.24GlobeNewswireSanofi: Information concerning the total number of voting rights and shares - April 2024

20.05.24GlobeNewswirePress Release: Dupixent® late-breaking data from NOTUS confirmatory phase 3 COPD study presented at ATS and published in NEJM

20.05.24EN, Sanofi-AventisPress Release: Dupixent® late-breaking data from NOTUS confirmatory phase 3 COPD study presented at ATS and published in NEJM

Sanofi News

Sanofi News: auf dieser Seite finden Sie alle Sanofi News und Nachrichten zur Sanofi Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Sanofi News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Sanofi News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.